Ovid Therapeutics Inc.
Ovid Therapeutics Inc.
OVID
Valuace
70
Růst
20
Zdraví
74
Cena
$ 1.31
Dnes
--0.02 (-1.26%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.1B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-81%
ROA
-57%
PE
-3
PS
16
Cena 1R
0-2
⌀ Cena
0.95
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
10-03-2026
Poslední dividenda

Profil

Ovid Therapeutics Inc., biofarmaceutická společnost, vyvíjí účinné léky pro pacienty a rodiny s neurologickými poruchami ve Spojených státech. Společnost vyvíjí OV101, lékový kandidát, který je v klinických studiích fáze 2A pro léčbu křehkého X syndromu; OV329, inhibitor GABA aminotransferázy pro léčbu záchvatů spojených s tuberózou, komplexem sklerózy a infantilními spazmy; a OV350, malou molekulu pro léčbu epilepsií. Dále vyvíjí OV882, krátkou genovou terapii vlasové RNA pro léčbu angelmanova syndromu, a OV815 pro léčbu kinesinové skupiny proteinů spojených s neurologickou poruchou. Společnost má licenční smlouvy a smlouvy o spolupráci se společnostmi Healx, AstraZeneca AB, H. Lundbeck A/S a Northwestern University, jakož i Marinus Pharmaceuticals, Inc. Společnost byla založena v roce 2014 a sídlí v New Yorku.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
23
Založení
2017-05-05
Adresa
1460 Broadway
CEO
Jeremy Max Levin Ba Zoology, Dphil, Mb Bchir,

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018201720162015
Total Revenues7.37.30.60.41.5208.412.60.00.00.00.00.0
Cost of Revenues0.10.30.00.00.00.00.00.00.00.00.00.0
Gross Profit7.07.00.60.41.5208.412.60.00.00.00.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.70.16.30.10.10.20.20.10.10.1
Cost of Revenues0.00.00.00.00.00.00.00.00.4-108.9
Gross Profit0.40.16.30.10.10.20.20.1-0.3109.0
Operating Income TTM 20252024202320222021202020192018201720162015
R&D Expenses0.00.00.028.624.646.963.442.233.850.09.66.6
Selling General & Admin Expenses0.00.00.031.132.437.230.619.319.115.013.06.6
Depreciation & Amortization0.30.30.61.61.40.20.30.30.10.10.10.0
Total Operating Expenses49.449.462.559.757.184.294.061.452.965.022.513.2
Operating Income-42.4-42.4-61.9-59.3-55.5124.2-81.4-61.4-52.9-65.0-22.5-13.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.010.55.3
Selling General & Admin Expenses0.00.00.00.00.00.00.00.07.46.8
Depreciation & Amortization0.00.00.10.10.20.20.10.10.40.4
Total Operating Expenses12.712.611.312.710.813.420.717.617.912.1
Operating Income-12.3-12.5-5.1-12.6-10.7-13.2-20.5-17.4-18.2-12.0
Net Income TTM 20252024202320222021202020192018201720162015
Interest Income0.00.03.94.90.00.00.00.91.00.20.00.0
Interest Expense0.00.00.00.0-2.80.00.00.00.00.00.00.0
Other Expense25.025.035.56.91.40.00.40.91.00.20.10.0
IBT-17.4-17.4-26.4-52.3-54.2124.2-81.0-60.5-52.0-64.8-22.4-13.2
Income Tax Expense0.00.00.00.0-2.81.3-0.3-1.21.0-0.10.00.0
Net Income-17.4-17.4-26.4-52.3-51.4122.8-80.7-59.3-52.0-64.8-22.4-13.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.00.0
Interest Expense0.00.00.00.00.00.00.00.01,536.10.0
Other Expense22.00.40.42.31.5-0.829.05.72.90.8
IBT9.7-12.2-4.7-10.2-9.3-14.08.5-11.7-15.3-11.3
Income Tax Expense0.00.00.00.00.00.00.00.00.00.0
Net Income9.7-12.2-4.7-10.2-9.3-14.08.5-11.7-15.3-11.3
Per Share Data TTM 20252024202320222021202020192018201720162015
EPS$0.00$0.00$0.00$-0.74$-0.73$1.78$-1.38$-1.51$-2.11$-3.35$-1.14$-0.67
EPS Diluted$0.00$0.00$0.00$-0.74$-0.73$1.76$-1.38$-1.51$-2.11$-3.35$-1.14$-0.67
Shares Outstanding81.773.770.970.670.467.558.539.224.619.319.619.6
Diluted Shares Outstanding81.773.770.970.670.468.158.539.224.619.319.619.6
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.22$-0.16
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.22$-0.16
Shares Outstanding81.771.171.171.071.071.070.970.770.770.6
Diluted Shares Outstanding81.771.171.171.071.071.071.270.770.770.6
Current Assets TTM 2024202320222021202020192018201720162015
Cash And Equivalents29.726.327.0129.0187.872.041.936.587.151.969.9
Short Term Investments47.326.878.884.10.00.034.85.00.00.00.0
Total Cash & ST Investments77.053.1105.8129.0187.872.076.741.587.151.969.9
Accounts Receivable0.00.00.00.00.00.11.10.00.00.00.1
Inventory0.00.00.00.00.00.00.00.00.00.20.0
Other Current Assets3.92.93.82.42.72.71.92.81.50.20.3
Total Current Assets80.955.9109.6131.4190.574.879.844.388.652.470.3
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents20.628.421.126.315.029.730.827.057.471.6
Short Term Investments5.09.921.926.847.747.359.578.829.624.9
Total Cash & ST Investments25.638.343.053.162.777.090.3105.887.196.5
Accounts Receivable0.00.00.00.00.00.00.00.00.00.0
Inventory0.00.00.00.00.00.00.00.00.00.0
Other Current Assets3.23.72.92.93.13.92.93.84.65.7
Total Current Assets28.842.145.955.965.880.993.2109.691.7102.2
Long-Term Assets TTM 2024202320222021202020192018201720162015
Net Property, Plant & Equipment14.013.214.716.10.20.10.10.10.10.00.0
Goodwill0.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.10.20.00.00.00.00.00.00.00.0
Long-Term Investments23.021.017.65.61.60.00.00.00.00.00.0
Other Long-Term Assets0.21.92.02.01.90.60.52.90.80.50.0
Total Long-Term Assets37.236.234.423.94.11.11.03.40.90.60.1
Total Assets118.192.2144.0155.3194.575.980.847.689.553.070.4
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment12.212.512.913.213.614.014.314.715.015.4
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.10.20.20.10.20.20.3
Long-Term Investments20.920.920.921.021.123.022.019.616.116.5
Other Long-Term Assets1.91.91.91.92.00.02.00.02.02.0
Total Long-Term Assets35.035.335.736.236.837.238.434.433.334.1
Total Assets63.877.481.792.2102.7118.1131.6144.0125.0136.2
Current Liabilities TTM 2024202320222021202020192018201720162015
Accounts Payable4.73.23.72.07.15.43.33.82.00.90.7
Short-Term Debt1.31.31.20.50.00.00.00.00.00.00.0
Other Current Liabilities8.16.06.54.57.714.47.35.14.02.91.6
Current Liabilities14.110.511.57.014.822.110.58.86.03.72.3
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable1.74.02.03.22.74.73.63.71.23.8
Short-Term Debt1.41.41.41.31.31.31.31.21.20.9
Other Current Liabilities3.03.66.06.07.68.14.06.56.25.4
Current Liabilities6.88.99.310.511.614.18.911.58.710.1
Long-Term Liabilities TTM 2024202320222021202020192018201720162015
Long-Term Debt1.013.414.816.00.00.00.00.00.00.00.0
Capital Leases14.114.816.016.50.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities29.223.956.223.014.832.310.88.86.03.72.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.012.713.113.413.815.114.414.815.115.4
Capital Leases1.414.114.414.815.114.115.714.816.316.3
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities19.221.622.423.926.429.253.356.223.725.5
Total Common Equity TTM 2024202320222021202020192018201720162015
Common Stock0.10.10.10.10.10.10.10.00.00.00.0
Retained Earnings-281.0-304.3-277.9-225.5-171.4-294.2-213.2-152.7-100.7-61.8-13.5
Comprehensive Income0.00.00.00.00.00.00.00.0-0.10.00.0
Total Common Equity88.968.287.8132.3179.743.670.038.883.449.368.1
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings-331.4-319.2-314.5-304.3-295.0-281.0-289.6-277.9-262.5-251.3
Comprehensive Income-0.1-0.10.00.00.00.00.00.00.00.0
Total Common Equity44.755.859.368.276.388.978.387.8101.3110.7
Other TTM 2024202320222021202020192018201720162015
Total Debt16.414.816.016.50.00.00.00.00.00.00.0
Book Value88.968.287.8132.3179.743.670.038.883.449.368.1
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value44.755.859.368.276.388.978.387.8101.3110.7
Cash Flow From Operating Activities TTM 20252024202320222021202020192018201720162015
Net Income-29.7-17.4-26.4-52.3-54.2122.8-81.0-60.5-52.0-64.8-22.4-13.2
Depreciation & Amortization1.10.30.61.61.40.20.30.30.10.10.10.0
Stock-Based Compensation7.14.86.37.36.65.17.55.27.16.43.61.5
Change Working Capital6.1-4.1-0.22.4-8.2-16.821.83.9-0.81.00.91.8
Change In Accounts Receivable0.00.00.00.00.00.00.00.00.00.00.00.0
Change In Accounts Payable1.0-1.2-0.51.8-5.21.72.3-0.71.61.10.20.6
Change In Inventories0.00.00.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items-34.5-21.9-36.3-4.7-0.87.3-0.20.00.025.93.64.4
Cash from Operations-52.90.00.0-45.8-55.2118.6-51.6-51.1-45.6-31.5-17.8-5.5
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income9.7-12.2-4.7-10.2-9.3-14.08.5-11.7-15.3-11.3
Depreciation & Amortization0.00.00.10.10.10.20.10.10.40.4
Stock-Based Compensation1.20.01.21.30.00.00.02.01.81.6
Change Working Capital0.1-1.7-1.2-1.3-0.9-1.74.2-1.73.70.0
Change In Accounts Receivable0.00.00.00.00.00.00.00.00.00.0
Change In Accounts Payable0.2-2.22.0-1.20.5-2.01.1-0.12.5-2.5
Change In Inventories0.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items-21.41.0-0.2-0.20.00.6-27.1-5.4-2.3-1.2
Cash from Operations0.00.00.00.00.00.00.00.0-11.9-10.1
Cash Flow From Investing Activities TTM 20252024202320222021202020192018201720162015
Capital Expenditure-0.10.0-0.10.0-1.4-0.2-0.4-0.2-0.40.0-0.2-0.1
Acquisitions52.90.00.00.0-2.5-1.60.30.20.30.00.00.0
Investments-134.7-91.9-73.2-112.4-173.0-1,632.0-10.0-34.8-50.00.00.00.0
Sales of Investment115.042.0128.0120.090.01,637.445.05.045.00.00.00.0
Other Investing Activities-32.60.00.0-10.1-1.0-5.4-0.3-0.2-0.30.00.00.0
Cash from Investing-19.90.00.0-2.6-87.9-1.834.6-30.0-5.40.0-0.2-0.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.00.00.00.00.00.00.00.00.0
Acquisitions0.00.00.00.00.00.00.00.048.54.4
Investments-77.1-4.9-4.9-4.9-16.7-9.7-37.0-9.8-58.5-29.4
Sales of Investment5.010.017.010.038.010.050.030.010.025.0
Other Investing Activities0.00.00.00.00.00.00.00.0-48.5-4.4
Cash from Investing0.00.00.00.00.00.00.00.0-48.5-4.4
Cash Flow From Financing Activities TTM 20252024202320222021202020192018201720162015
Debt Repaid-30.00.00.00.00.00.00.00.00.00.00.00.0
Debt Issued30.014.8-1.2-0.516.50.00.00.00.00.00.00.0
Issuance of Common Stock0.80.00.00.5180.70.046.786.40.069.80.00.0
Repurchase of Common Stock-15,448.80.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities30.50.00.030.5-180.50.90.30.10.3-3.00.070.6
Cash from Financing30.80.00.030.50.20.947.186.50.366.70.070.6
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued1.4-12.7-0.3-0.3-0.3-1.30.7-30.329.70.0
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.2
Repurchase of Common Stock0.00.00.00.00.00.00.00.0-15,448.80.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.030.00.2
Cash from Financing0.00.00.00.00.00.00.00.030.00.2
Cash position TTM 20252024202320222021202020192018201720162015
Net Change in Cash-41.9-13.1-0.7-17.8-142.9117.730.15.4-50.635.2-18.065.1
Closing Cash Balance29.715.128.229.046.8189.772.041.936.587.151.969.9
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-7.5-7.87.3-5.211.3-14.7-1.13.7-30.4-14.2
Closing Cash Balance15.120.630.323.126.315.029.730.827.059.4
Free Cash Flow TTM 20252024202320222021202020192018201720162015
Free Cash Flow-53.0-38.3-56.0-45.9-56.6118.4-52.0-51.3-45.9-31.5-18.0-5.5
Real Free Cash Flow-60.1-43.1-62.3-53.2-63.2113.4-59.5-56.5-53.0-37.9-21.6-7.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-10.4-12.9-4.8-10.3-10.0-15.0-14.3-16.7-11.9-10.1
Real Free Cash Flow-11.6-12.9-6.0-11.6-10.0-15.0-14.3-18.7-13.7-11.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-2.9-2-1.4
P/S16.1135.29.4
P/B2.42.45.2
P/FCF-2.6-2.6-1.5
Market cap$0.1$0.8
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets2.2 %19.5 %0 %
Debt to Income-8.1 %-7.9 %0 %
Debt to Free cash flow-3.4 %-258 %0 %
Interest expense percentage0 %42.6 %44.7 %
Current ratio4.2 9.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-39 %93.6 %0 %
ROA-27.3 %70.6 %0 %
CapEx to Revenue-0.1 %38.7 %0 %
RaD to Revenue0 %1986.1 %0 %
ROEM315,304.3 -527665

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin99.7 %8740.6 %68.7 %
Operating margin-618.3 %-4137.2 %35.5 %
Net margin-549.6 %73693.3 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding71.1 mil 50.5 mil
Employee count0.0 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader